Concomitant Intraarterial Cisplatin, Intravenous 5-Fluorouracil, and Split-Course Radiation Therapy for Locally Advanced Unresectable Pancreatic Adenocarcinoma: A Phase II Study of the Puget Sound Oncology Consortium (PSOC-703)

R. Thomas, Charles; L. Weiden, Paul; William Traverso, L.; Thompson, Tove

doi:10.1097/00000421-199704000-00012

Public

Concomitant Intraarterial Cisplatin, Intravenous 5-Fluorouracil, and Split-Course Radiation Therapy for Locally Advanced Unresectable Pancreatic Adenocarcinoma: A Phase II Study of the Puget Sound Oncology Consortium (PSOC-703)

Published in American Journal of Clinical Oncology • Apr 1, 1997

Authors:

Charles R. Thomas

Paul L. Weiden

L. William Traverso

Abstract

A Gastrointestinal Tumor Study Group (GITSG) protocol showed a survival benefit for patients with locally advanced unresectable pancreatic adenocarcinoma when treated with split-course radiation therapy and bolus intravenous (i.v.) 5-fluorouracil (5-FU) as compared with survival achieved with radiat...

Subject

Medicine

Concomitant

Radiation therapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!